Does crowdfunding work in biotech?

Online fundraising has helped bring movies, comic books and even medical devices to reality, and a new study says the method could be beneficial for drug developers at the earliest stages. In a study published in Drug Discovery Today, researchers looked at 97 crowdfunding campaigns and concluded that while the model can't replace the value of grants and private investments, it presents a viable source of cash for proof-of-concept studies. More

Suggested Articles

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.

Grid Therapeutics is planning to start trials of its lead cancer immunotherapy GT103 next year after raising $5 million in second-round financing.

The IPO comes as the Flagship startup prepares to test its lead inflammatory disease and anticancer microbial strains in humans.